Weight-adjusted aspirin for cardiovascular prevention

Lancet. 2018 Aug 4;392(10145):361-362. doi: 10.1016/S0140-6736(18)31307-2. Epub 2018 Jul 17.

Authors

Katherine N Theken¹, Tilo Grosser²

Affiliations

¹ Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
² Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: tilo@pennmedicine.upenn.edu.

PMID: 30017553
DOI: 10.1016/S0140-6736(18)31307-2

No abstract available

Publication types

Comment

MeSH terms

Aspirin*
Cardiovascular Diseases
Platelet Aggregation Inhibitors*
Primary Prevention

Substances

Platelet Aggregation Inhibitors
Aspirin

Grants and funding

U54 HL117798/HL/NHLBI NIH HHS/United States